Given the above correlations, and the role of GSDMB in promoting an aggressive breast cancer cell phenotype [34], we next assessed if the over-expression of GSDMB could also influence the prognosis of HER2-high tumours. The gene discussed is GSDMB; the disease is neoplasm.